Placental Protein 13 Serum Endoglin and Uterine Doppler Indeces as Predictors of Pre-eclampsia

Cairo University (CU)

Status: Completed

Conditions: Preeclampsia

Treatments: Other: ultrasound monitoring

Study type: Observational

Funder types: Other

Identifiers

NCT02350036

125

Details and patient eligibility

About

50 pregnant females were divided in two groups, twenty five as a control group and twenty five as high risk group; they were subjected to uterine artery Doppler, measurement of maternal serum and detection of (MTHFR) gene polymorphisms in first trimester at 11 to 14 weeks of gestation, all pregnancies were followed until 40 weeks for development of pre-eclampsia

Full description

50 pregnant females were divided in two groups, twenty five as a control group and twenty five as high risk group; they were subjected to uterine artery Doppler, measurement of maternal serum (pp-13) and detection of (MTHFR) gene polymorphisms in first trimester at 11 to 14 weeks of gestation, all pregnancies were followed until 40 weeks for development of pre-eclampsia

Enrollment: 50 patients

Sex: Female

Ages: 20 to 40 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• pregnant women at 11 to 14 weeks of gestation

Exclusion criteria

• fetal anomalies other medical diseases as diabetes mellitus, renal or liver diseases

Trial design

50 participants in 2 patient groups

preeclmapsia

Description:

women developed preeclampsia. ultrasound monitoring and uterine artery Doppler

Treatment:

Other: ultrasound monitoring

control

Description:

women with normal blood pressure all through pregnancy. ultrasound monitoring and uterine artery Doppler

Treatment:

Other: ultrasound monitoring